| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
21,040,000 |
| Market
Cap: |
1.00(B) |
| Last
Volume: |
64,582 |
Avg
Vol: |
95,707 |
| 52
Week Range: |
$41.52 - $67.92 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
NASDAQ INDUSTRIAL |
|
S&P SMALLCAP 600 |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile USANA Health Sciences develops and manufactures science-based nutritional, personal care and skincare products. Co.'s principal product lines include: USANA® Nutritionals Optimizers, which consists of targeted supplements designed to meet individual health and nutritional needs; Essentials/CellSentials®, which includes primary vitamin and mineral supplements that provide a foundation of body nutrition for every age group with children 13 months of age; Foods, which includes meal replacement shakes, snack bars, and other related products that provide macro-nutrition in various formats; and Personal Care and Skincare, which includes its science-based personal care products and Celavive.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
45,419 |
45,731 |
62,314 |
140,742 |
| Total Sell Value |
$2,164,898 |
$2,180,413 |
$3,239,295 |
$8,241,627 |
| Total People Sold |
11 |
11 |
14 |
16 |
| Total Sell Transactions |
13 |
14 |
25 |
50 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Neidig Brent |
Chief Officer & MD of China |
• – – |
2022-02-03 |
4 |
D |
$93.82 |
$79,747 |
D/D |
(850) |
1,065 |
|
- |
|
| Neidig Brent |
Chief Officer & MD of China |
• – – |
2022-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,915 |
1,915 |
|
- |
|
| Sinnott Robert A |
Chief Scientific Officer |
• – – |
2022-02-03 |
4 |
D |
$93.82 |
$85,376 |
D/D |
(910) |
1,118 |
|
- |
|
| Sinnott Robert A |
Chief Scientific Officer |
• – – |
2022-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,028 |
2,028 |
|
- |
|
| Ding Xia |
Director |
– • – |
2022-01-25 |
4 |
D |
$98.48 |
$7,386 |
D/D |
(75) |
224 |
|
- |
|
| Ding Xia |
Director |
– • – |
2022-01-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
299 |
299 |
|
- |
|
| Noot Walter |
Chief Operating Officer |
• – – |
2021-12-16 |
4 |
S |
$102.25 |
$633,232 |
D/D |
(6,193) |
0 |
|
23% |
|
| Noot Walter |
Chief Operating Officer |
• – – |
2021-12-16 |
4 |
OE |
$62.20 |
$385,205 |
D/D |
6,193 |
6,193 |
|
- |
|
| Macuga Daniel A. |
Chief Communications Officer |
• – – |
2021-12-08 |
4 |
S |
$100.86 |
$37,116 |
D/D |
(368) |
0 |
|
19% |
|
| Mulham David Mulham |
Chief Field Development Office |
• – – |
2021-12-07 |
4 |
S |
$101.50 |
$88,610 |
D/D |
(873) |
4,081 |
|
20% |
|
| Mulham David Mulham |
Chief Field Development Office |
• – – |
2021-11-11 |
4 |
S |
$100.74 |
$111,922 |
D/D |
(1,111) |
5,523 |
|
22% |
|
| Neidig Brent |
Chief Officer & MD of China |
• – – |
2021-11-05 |
4 |
S |
$102.88 |
$18,004 |
D/D |
(175) |
0 |
|
21% |
|
| Iiekking G Doug |
CFO |
• – – |
2021-11-05 |
4 |
S |
$103.48 |
$22,661 |
D/D |
(219) |
1,400 |
|
21% |
|
| Guest Kevin |
C.E.O. |
• – – |
2021-11-04 |
4 |
S |
$102.35 |
$108,181 |
D/D |
(1,057) |
0 |
|
22% |
|
| Mulham David Mulham |
Chief Field Development Office |
• – – |
2021-11-04 |
4 |
S |
$101.77 |
$142,274 |
D/D |
(1,398) |
6,634 |
|
22% |
|
| Jones Paul A. |
Chief Leadership Dev Officer |
• – – |
2021-11-03 |
4 |
S |
$101.25 |
$216,267 |
D/D |
(2,136) |
5,578 |
|
20% |
|
| Sinnott Robert A |
Chief Scientific Officer |
• – – |
2021-11-03 |
4 |
S |
$101.46 |
$32,264 |
D/D |
(318) |
0 |
|
20% |
|
| Brown Jim |
President |
• – – |
2021-11-03 |
4 |
S |
$101.57 |
$56,779 |
D/D |
(559) |
0 |
|
20% |
|
| Mulham David Mulham |
Chief Field Development Office |
• – – |
2021-11-03 |
4 |
S |
$99.63 |
$127,234 |
D/D |
(1,277) |
8,032 |
|
20% |
|
| Fuller Gilbert A |
Director |
– • – |
2021-11-01 |
4 |
S |
$98.40 |
$30,700 |
D/D |
(312) |
0 |
|
17% |
|
| Noot Walter |
Chief Operating Officer |
• – – |
2021-10-29 |
4 |
S |
$95.62 |
$33,945 |
D/D |
(355) |
0 |
|
16% |
|
| Foukas Joshua |
Chief Legal Officer |
• – – |
2021-10-28 |
4 |
S |
$95.17 |
$17,226 |
D/D |
(181) |
0 |
|
13% |
|
| Winssinger Frederic J |
Director |
– • – |
2021-10-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
312 |
1,902 |
|
- |
|
| Fleming John Turman |
Director |
– • – |
2021-10-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
312 |
1,163 |
|
- |
|
| Pelosi Peggie |
Director |
– • – |
2021-10-27 |
4 |
D |
$99.48 |
$17,807 |
D/D |
(179) |
1,869 |
|
- |
|
2038 Records found
|
|
Page 16 of 82 |
|
|
0.31 (0.66%) 
